Skip to content
Newsletter
Toggle navigation
Newsletter
HCP Portal
Search for:
Search
About PH
Toggle menu
What is pulmonary hypertension?
Classification
Causes
Symptoms
Diagnosis
Living with PH
Treatments
Toggle menu
Treatment options
Approved treatments
Experimental treatments
Stem cell therapy
News
Columns
Toggle menu
Blooming Hope
— Anna Jeter
Life as a Caregiver
— Colleen Steele
PHighting Words
— Mike Naple
The PHlip-side
– Jolie Lizana
Worth the PHight
— Jen Cueva
Archived columns
Recharged and Rewired
— Brittany Foster
Chronically Uncool
— Ellie Bird
In Life With PH
— Serena Lawrence
Life After PH
— Kathleen Sheffer
My Respiration Situation
— Karen Schultz
Collections
Toggle menu
Newly diagnosed with PH
Living well with PH
Mental health and PH
Forums
Advocacy partners
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
HCP Portal
Actelion Pharmaceuticals US, Inc., —
Articles by Actelion Pharmaceuticals US, Inc.
Recent Posts
ADM may offer new clues for protecting lungs in BPD-PH
2 proteins could be targets for future CTEPH treatment: Study
Access to PAH drug Winrevair in Canada advances by ‘critical step’
On the slow journey toward a cure, every day with PH matters
Merck plans Phase 3 Winrevair study after Phase 2 trial hits goal
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Comments
This field is for validation purposes and should be left unchanged.
Email Address
(Required)
Δ
